JP2022530471A5 - - Google Patents
Info
- Publication number
- JP2022530471A5 JP2022530471A5 JP2021563360A JP2021563360A JP2022530471A5 JP 2022530471 A5 JP2022530471 A5 JP 2022530471A5 JP 2021563360 A JP2021563360 A JP 2021563360A JP 2021563360 A JP2021563360 A JP 2021563360A JP 2022530471 A5 JP2022530471 A5 JP 2022530471A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- neuroprotective compound
- compound
- neurodegeneration
- formulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962838216P | 2019-04-24 | 2019-04-24 | |
| US62/838,216 | 2019-04-24 | ||
| PCT/CA2020/050547 WO2020215164A1 (en) | 2019-04-24 | 2020-04-24 | Compositions and methods for use of cannabinoids for neuroprotection |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022530471A JP2022530471A (ja) | 2022-06-29 |
| JP2022530471A5 true JP2022530471A5 (cg-RX-API-DMAC7.html) | 2023-05-02 |
| JP7633179B2 JP7633179B2 (ja) | 2025-02-19 |
Family
ID=72940570
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021563360A Active JP7633179B2 (ja) | 2019-04-24 | 2020-04-24 | 神経保護のためのカンナビノイドの組成物及び使用方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230043428A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3958856A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7633179B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220080045A (cg-RX-API-DMAC7.html) |
| CN (1) | CN114007603A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020261515B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3134764A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL287536B2 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2021012960A (cg-RX-API-DMAC7.html) |
| SG (1) | SG11202111809XA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020215164A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115006404A (zh) * | 2022-08-09 | 2022-09-06 | 昆药集团股份有限公司 | 一种具有视神经保护功效的药物组合物及其应用 |
| US20240139272A1 (en) * | 2022-10-27 | 2024-05-02 | Kemin Industries, Inc. | Use of a spearmint extract for retina neurotrophism |
| AU2024206205A1 (en) * | 2023-01-04 | 2025-07-17 | Florascience Inc. | Cannabinoids for use in the treatment of a neurodegenerative disease or condition |
| IL327899A (en) * | 2023-10-23 | 2026-06-01 | Inmed Pharmaceuticals Inc | Compositions and methods for use of cannabinol compounds in neuroprotection |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2471987B (en) * | 2008-06-04 | 2012-02-22 | Gw Pharma Ltd | Anti-tumoural effects of cannabinoid combinations |
| BR112013012468A2 (pt) * | 2010-11-18 | 2016-09-06 | Pier Pharmaceuticals | método de tratar um indivíduo com um distúrbio sensível a canabinóide, de estabelecer uma dose ideal, de tratar um indivíduo com um distúrbio de apneia do sono, e, kit |
| MX2017005277A (es) * | 2014-10-21 | 2018-01-11 | United Cannabis Corp | Extractos de cannabis y métodos de preparación y uso de la misma. |
| MA41299A (fr) * | 2014-12-30 | 2017-11-07 | Axim Biotechnologies Inc | Solutions ophtalmiques pour le traitement du glaucome et de la conjonctivite |
| US20170266153A1 (en) * | 2015-02-27 | 2017-09-21 | Ebbu, LLC | Compositions purposefully selected comprising purified cannabinoids and/or purified terpenes |
| AU2016225026A1 (en) * | 2015-02-27 | 2017-09-07 | Canopy Growth Corporation | Compositions comprising combinations of purified cannabinoids, with at least one flavonoid, terpene, or mineral |
| EP3261629A4 (en) * | 2015-02-27 | 2018-12-05 | Ebbu, LLC | Compositions comprising combinations of purified cannabinoids, with at least one flavonoid, terpene, or mineral |
| US20160282371A1 (en) * | 2015-03-28 | 2016-09-29 | Quantalytical Labs Inc. | Solid Phase Extraction, Derivatization with Crown Ethers, and Mass Spectrometry, Methods, Reagents and Kits |
| IL248149B (en) * | 2016-09-29 | 2020-03-31 | Garti Nissim | Dilutable formulations of cannbinoids and processes for their preparation |
| JP7225103B2 (ja) * | 2016-10-11 | 2023-02-20 | ジービーエス グローバル バイオファーマ,インコーポレイテッド | 神経変性疾患を処置するためのカンナビノイド含有複合混合物 |
| WO2018118197A1 (en) * | 2016-12-21 | 2018-06-28 | Richard Postrel | Healthier aging in domesticated animals |
| CN110997006A (zh) * | 2017-05-08 | 2020-04-10 | 因美制药公司 | 眼部药物递送制剂 |
| WO2018205038A1 (en) * | 2017-05-12 | 2018-11-15 | Tetra Bio-Pharma Inc. | Compositions comprising cannabinoids and terpenes useful in the treatment of cancer and vascular ocular disorders via inhibition of hedgehog signalling |
| US20170348277A1 (en) * | 2017-08-02 | 2017-12-07 | Bryan Ray Ruiz | Cannabinoid formulation including a vasodilator and ocular delivery of the same |
-
2020
- 2020-04-24 CA CA3134764A patent/CA3134764A1/en active Pending
- 2020-04-24 JP JP2021563360A patent/JP7633179B2/ja active Active
- 2020-04-24 KR KR1020217036628A patent/KR20220080045A/ko not_active Withdrawn
- 2020-04-24 WO PCT/CA2020/050547 patent/WO2020215164A1/en not_active Ceased
- 2020-04-24 CN CN202080046190.4A patent/CN114007603A/zh active Pending
- 2020-04-24 IL IL287536A patent/IL287536B2/en unknown
- 2020-04-24 AU AU2020261515A patent/AU2020261515B2/en active Active
- 2020-04-24 EP EP20794650.0A patent/EP3958856A4/en active Pending
- 2020-04-24 SG SG11202111809XA patent/SG11202111809XA/en unknown
- 2020-04-24 MX MX2021012960A patent/MX2021012960A/es unknown
- 2020-04-24 US US17/606,003 patent/US20230043428A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW401300B (en) | Antiallergic composition for ophthalmic or nasal use | |
| TWI773706B (zh) | 用於眼用活性藥物成分輸送的固體環糊精複合物之製備 | |
| TWI618539B (zh) | 無刺激性眼用聚乙烯吡咯啶酮-碘組成物 | |
| CN100453066C (zh) | 利用结膜下储存库的药物释放系统 | |
| JP7716996B2 (ja) | 薬剤を含む水性組成物のpHを安定化させるための方法 | |
| AU2009329024A1 (en) | Curcuminoids and its metabolites for the application in ocular diseases | |
| SA516380321B1 (ar) | مستحضرات للعين لتوصيل الدواء إلى الجزء الخلفي من العين | |
| WO2003070219A1 (en) | Drug delivery system for the subconjunctival administration of fine grains | |
| JP2021525710A (ja) | 眼充血を治療するための組成物およびそれを用いて眼充血を治療するための方法 | |
| JP2018521117A (ja) | シクロスポリンa/シクロデキストリンナノ粒子の形成 | |
| KR102555091B1 (ko) | 약물 전달 및 전안부 보호를 위한 안구용 제제 | |
| CN104661682A (zh) | 水性液剂 | |
| JP2021091697A (ja) | 水性点眼点鼻用組成物 | |
| López-Cano et al. | New trends towards glaucoma treatment: Topical osmoprotective microemulsions loaded with latanoprost | |
| JP2022547231A5 (cg-RX-API-DMAC7.html) | ||
| KR20210158355A (ko) | 디쿠아포솔을 포함하는 점안 조성물 | |
| KR20100051811A (ko) | 눈에 수용체 티로신 키나제 저해(rtki) 화합물을 전달하기 위한 약제학적 제제 | |
| US12576126B2 (en) | Nanoemulsion ophthalmic composition comprising cyclosporine and menthol, and preparation method thereof | |
| FR3077984A1 (fr) | Composition multiusage de torasemide | |
| TW201705956A (zh) | 唑系抗真菌藥之對眼瞼皮膚的投與 | |
| RU2521337C1 (ru) | Фармацевтическая композиция для лечения заболеваний глаз, связанных с нарушением метаболизма в тканях глаза и воспалительным поражением тканей глаза | |
| JP2022540572A (ja) | 眼疾患を治療するための組成物および方法 | |
| TWI801053B (zh) | 眼用組合物 | |
| CN104997729A (zh) | 含磺丁基醚-β-环糊精的普拉洛芬滴眼液及其制备方法 | |
| TW202345853A (zh) | 無防腐劑的眼科藥物乳劑及其應用 |